Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fostamatinib in rheumatoid arthritis (OSKIRA-Asia-1X)
NCT01640054Phase 2Terminated
- Sponsor
- AstraZeneca
- Start
- Jul 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of fostamatinib in rheumatoid arthritis (RA), sponsored by AstraZeneca. Started Jul 2012; status: terminated.
02
Drugs
fostamatinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01640054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01640054.